 |
 |

Use of Pharmacotherapy for Smoking Cessation in Italy
Arch Intern Med. 2009;169(20):1927-1928.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In a cluster-randomized smoking cessation trial conducted in Germany on 577 smokers, cost-free nicotine replacement therapy (NRT) or bupropion hydrochloride reduced smoking-related morbidity at low cost.1 This adds to the accumulated evidence that NRT, bupropion, and varenicline tartrate significantly increase cessation rate and are generally well tolerated by smokers.2-3
Using data from 6 population-based surveys conducted in Italy between 2002 and 2007, we showed that pharmacotherapy for smoking cessation was used by less than 10% of smokers who had made at least 1 quit attempt.4 We provide herein updated information on the issue.
Methods
Data were derived analyzing data from a survey conducted in 2008 on 3035 individuals (1459 men and 1576 women) representative of the Italian population 15 years and older.5 The data were collected by trained interviewers using a structured questionnaire in the context of a computer-assisted personal in-house interview. Information on sociodemographic characteristics and on smoking behavior and . . . [Full Text of this Article] Results
Comment
AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED LETTERS
Use of Pharmacotherapy for Smoking Cessation in Italy
Arch Intern Med. 2009;169(20):1927-1928.
EXTRACT
| FULL TEXT
The Impact of Repeated Cycles of Pharmacotherapy on Smoking Cessation: A Longitudinal Cohort Study
A. Paula Cupertino, Jo A. Wick, Kimber P. Richter, Laura Mussulman, Niaman Nazir, and Edward F. Ellerbeck
Arch Intern Med. 2009;169(20):1928-1930.
EXTRACT
| FULL TEXT
|